Glycogen storage disease type I other diagnostic studies
Glycogen storage disease type I Microchapters |
Differentiating Glycogen storage disease type I from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Glycogen storage disease type I other diagnostic studies On the Web |
American Roentgen Ray Society Images of Glycogen storage disease type I other diagnostic studies |
FDA on Glycogen storage disease type I other diagnostic studies |
CDC on Glycogen storage disease type I other diagnostic studies |
Glycogen storage disease type I other diagnostic studies in the news |
Blogs on Glycogen storage disease type I other diagnostic studies |
Directions to Hospitals Treating Glycogen storage disease type I |
Risk calculators and risk factors for Glycogen storage disease type I other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Other Diagnostic Studies
The diagnosis is definitively confirmed by liver biopsy with electron microscopy and assay of glucose-6-phosphatase activity in the tissue and/or specific gene testing, available in recent years.
Prenatal diagnosis has been made by fetal liver biopsy at 18-22 weeks of gestation, but no fetal treatment has been proposed. Prenatal diagnosis is possible with fetal DNA obtained by chorionic villus sampling when a fetus is known to be at risk.